Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders

Pharmacology and Therapeutics

Volumn 143, Issue 3, 2014, Pages 253-264

  Hutson, Peter H ^a   Tarazi, Frank I ^b   Madhoo, Manisha ^a   Slawecki, Craig ^c   Patkar, Ashwin A ^d  

^a SHIRE   (United States)

^b MCLEAN HOSPITAL   (United States)

^c Clinical Content and Editorial Services   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

Amphetamine; Endocannabinoids; Endogenous opioids; Glutamate; Monoamines; Pharmacology

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; CANNABINOID; ENDOCANNABINOID; ENDORPHIN; GLUTAMIC ACID; BIOGENIC AMINE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; OPIATE PEPTIDE;

ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BIPOLAR I DISORDER; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MONOAMINERGIC SYSTEM; NARCOLEPSY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; ANIMAL; DRUG EFFECTS; MENTAL DISORDERS; METABOLISM; SYNAPTIC TRANSMISSION;

AMPHETAMINE; ANIMALS; BIOGENIC AMINES; GLUTAMIC ACID; HUMANS; MENTAL DISORDERS; OPIOID PEPTIDES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SYNAPTIC TRANSMISSION;

EID: 84905282946     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.03.005     Document Type: Review

References (187)

1. E. Acquas, C. Wilson, and H.C. Fibiger Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo J Pharmacol Exp Ther 281 1997 360 368
2. L.A. Adler, B. Dirks, P.F. Deas, A. Raychaudhuri, M.R. Dauphin, and R.A. Lasser et al. Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study J Clin Psychiatry 74 2013 694 702
3. K.C. Ahn, B.E. Bernier, M.T. Harnett, and H. Morikawa IP3 receptor sensitization during in vivo amphetamine experience enhances NMDA receptor plasticity in dopamine neurons of the ventral tegmental area J Neurosci 30 2010 6689 6699
4. F. Angelucci, S.H. Gruber, A. El Khoury, P.A. Tonali, and A.A. Mathe Chronic amphetamine treatment reduces NGF and BDNF in the rat brain Eur Neuropsychopharmacol 17 2007 756 762
5. B. Angrist, E. Peselow, M. Rubinstein, A. Wolkin, and J. Rotrosen Amphetamine response and relapse risk after depot neuroleptic discontinuation Psychopharmacology (Berl) 85 1985 277 283
6. H.M. Arnold, J. Fadel, M. Sarter, and J.P. Bruno Amphetamine-stimulated cortical acetylcholine release: role of the basal forebrain Brain Res 894 2001 74 87
7. A.F. Arnsten, and B.M. Li Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions Biol Psychiatry 57 2005 1377 1384
8. A.E. Autry, and L.M. Monteggia Brain-derived neurotrophic factor and neuropsychiatric disorders Pharmacol Rev 64 2012 238 258
9. R.J. Baldessarini, and F.I. Tarazi Brain dopamine receptors: a primer on their current status, basic and clinical Harv Rev Psychiatry 3 1996 301 325
10. N.T. Bello, and N.C. Liang The use of serotonergic drugs to treat obesity - is there any hope? Drug Des Devel Ther 5 2011 95 109
11. M.A. Benneyworth, and J.T. Coyle Altered acquisition and extinction of amphetamine-paired context conditioning in genetic mouse models of altered NMDA receptor function Neuropsychopharmacology 37 2012 2496 2504
12. S.M. Berman, R. Kuczenski, J.T. McCracken, and E.D. London Potential adverse effects of amphetamine treatment on brain and behavior: a review Mol Psychiatry 14 2009 123 142
13. S. Bernichtein, P. Touraine, and V. Goffin New concepts in prolactin biology J Endocrinol 206 2010 1 11
14. K.C. Berridge The debate over dopamine's role in reward: the case for incentive salience Psychopharmacology (Berl) 191 2007 391 431
15. C.W. Berridge, and B.D. Waterhouse The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes Brain Res Brain Res Rev 42 2003 33 84
16. G. Biala, M. Kruk, and B. Budzynska Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test J Physiol Pharmacol 60 2009 113 122
17. L.C. Bidwell, F.J. McClernon, and S.H. Kollins Cognitive enhancers for the treatment of ADHD Pharmacol Biochem Behav 99 2011 262 274
18. A.M. Boonstra, J. Oosterlaan, J.A. Sergeant, and J.K. Buitelaar Executive functioning in adult ADHD: a meta-analytic review Psychol Med 35 2005 1097 1108
19. K.E. Bosse, E.M. Jutkiewicz, M.E. Gnegy, and J.R. Traynor The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum Neuropharmacology 55 2008 755 762
20. T.E. Brown ADD/ADHD and impaired executive function in clinical practice Curr Psychiatry Rep 10 2008 407 411
21. I. Brunk, C. Sanchis-Segura, C. Blex, S. Perreau-Lenz, A. Bilbao, and R. Spanagel et al. Amphetamine regulates NR2B expression in Go2alpha knockout mice and thereby sustains behavioral sensitization J Neurochem 115 2010 234 246
22. J.S. Buyukdura, S.M. McClintock, and P.E. Croarkin Psychomotor retardation in depression: biological underpinnings, measurement, and treatment Prog Neuropsychopharmacol Biol Psychiatry 35 2011 395 409
23. M. Candy, L. Jones, R. Williams, A. Tookman, and M. King Psychostimulants for depression Cochrane Database Syst Rev 2008 CD006722
24. P.J. Carlson, M.C. Merlock, and T. Suppes Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation Bipolar Disord 6 2004 416 420
25. Y. Charnay, and L. Leger Brain serotonergic circuitries Dialogues Clin Neurosci 12 2010 471 487
26. R. Chen, C.A. Furman, M. Zhang, M.N. Kim, R.W. Gereau, and M. Leitges et al. Protein kinase Cβ is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice J Pharmacol Exp Ther 328 2009 912 920
27. E.S. Choe, K.T. Chung, L. Mao, and J.Q. Wang Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors Neuropsychopharmacology 27 2002 565 575
28. A. Colasanti, G.E. Searle, C.J. Long, S.P. Hill, R.R. Reiley, and D. Quelch et al. Endogenous opioid release in the human brain reward system induced by acute amphetamine administration Biol Psychiatry 72 2012 371 377
29. R. Cools, A.C. Roberts, and T.W. Robbins Serotoninergic regulation of emotional and behavioural control processes Trends Cogn Sci 12 2008 31 40
30. O. Corti, S. Lesage, and A. Brice What genetics tells us about the causes and mechanisms of Parkinson's disease Physiol Rev 91 2011 1161 1218
31. P. Cumming, D.F. Wong, N. Gillings, J. Hilton, U. Scheffel, and A. Gjedde Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein J Cereb Blood Flow Metab 22 2002 596 604
32. D.P. Daberkow, H.D. Brown, K.D. Bunner, S.A. Kraniotis, M.A. Doellman, and M.E. Ragozzino et al. Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals J Neurosci 33 2013 452 463
33. J.A. Dani, and D. Bertrand Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system Annu Rev Pharmacol Toxicol 47 2007 699 729
34. S. Datta, and R.R. Maclean Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence Neurosci Biobehav Rev 31 2007 775 824
35. J.R. Davidson Major depressive disorder treatment guidelines in America and Europe J Clin Psychiatry 71 2010 e04
36. J. Day, and H.C. Fibiger Dopaminergic regulation of cortical acetylcholine release Synapse 12 1992 281 286
37. J.C. Day, and H.C. Fibiger Dopaminergic regulation of septohippocampal cholinergic neurons J Neurochem 63 1994 2086 2092
38. C. DeBattista, K. Doghramji, M.A. Menza, M.H. Rosenthal, R.R. Fieve, and Modafinil in Depression Study Group Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study J Clin Psychiatry 64 2003 1057 1064
39. C. Dipace, U. Sung, F. Binda, R.D. Blakely, and A. Galli Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes Mol Pharmacol 71 2007 230 239
40. T.L. Doremus-Fitzwater, and L.P. Spear Age-related differences in amphetamine sensitization: effects of prior drug or stress history on stimulant sensitization in juvenile and adult rats Pharmacol Biochem Behav 96 2010 198 205
41. J.A. Dumas, and P.A. Newhouse The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation Pharmacol Biochem Behav 99 2011 254 261
42. B.W. Dunlop, P. Crits-Christoph, D.L. Evans, J. Hirschowitz, H.B. Solvason, and K. Rickels et al. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study J Clin Psychopharmacol 27 2007 614 619
43. S. Duong, K. Chung, and S.B. Wigal Metabolic, toxicological, and safety considerations for drugs used to treat ADHD Expert Opin Drug Metab Toxicol 8 2012 543 552
44. A.J. Eisch, and D. Petrik Depression and hippocampal neurogenesis: a road to remission? Science 338 2012 72 75
45. M. El Mansari, B.P. Guiard, O. Chernoloz, R. Ghanbari, N. Katz, and P. Blier Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder CNS Neurosci Ther 16 2010 e1 e17
46. M.B. El-Ghundi, T. Fan, J.M. Karasinska, J. Yeung, M. Zhou, and B.F. O'Dowd et al. Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice Psychopharmacology (Berl) 207 2010 599 618
47. M.R. Elphick, and M. Egertova The neurobiology and evolution of cannabinoid signalling Philos Trans R Soc Lond B Biol Sci 356 2001 381 408
48. E.A. Engleman, Z.A. Rodd, R.L. Bell, and J.M. Murphy The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy CNS Neurol Disord Drug Targets 7 2008 454 467
49. N.M. Enman, and E.M. Unterwald Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse Behav Brain Res 231 2012 217 225
50. S.V. Faraone Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths Phys Ther 34 2009 678 694
51. M. Fava, M.E. Thase, and C. DeBattista A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness J Clin Psychiatry 66 2005 85 93
52. E. Floor, and L. Meng Amphetamine releases dopamine from synaptic vesicles by dual mechanisms Neurosci Lett 215 1996 53 56
53. C. Flores, and J. Stewart Changes in astrocytic basic fibroblast growth factor expression during and after prolonged exposure to escalating doses of amphetamine Neuroscience 98 2000 287 293
54. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol Rev 83 2003 1017 1066
55. D.F. Fukushiro, F.S. Josino, L.P. Saito, J.M. Costa, L.H. Zanlorenci, and L.F. Berro et al. Differential effects of intermittent and continuous exposure to novel environmental stimuli on the development of amphetamine-induced behavioral sensitization in mice: implications for addiction Drug Alcohol Depend 124 2012 135 141
56. M.J. Garvey, S. Hwang, D. Teubner-Rhodes, J. Zander, and C. Rhem Dextroamphetamine treatment of mania J Clin Psychiatry 48 1987 412 413
57. Y. Geinisman Structural synaptic modifications associated with hippocampal LTP and behavioral learning Cereb Cortex 10 2000 952 962
58. Y. Geinisman, J.F. Disterhoft, H.J. Gundersen, M.D. McEchron, I.S. Persina, and J.M. Power et al. Remodeling of hippocampal synapses after hippocampus-dependent associative learning J Comp Neurol 417 2000 49 59
59. A.G. Gildengers, M.A. Butters, D. Chisholm, S.J. Anderson, A. Begley, and M. Holm et al. Cognition in older adults with bipolar disorder versus major depressive disorder Bipolar Disord 14 2012 198 205
60. M. Giorgetti, G. Hotsenpiller, P. Ward, T. Teppen, and M.E. Wolf Amphetamine-induced plasticity of AMPA receptors in the ventral tegmental area: effects on extracellular levels of dopamine and glutamate in freely moving rats J Neurosci 21 2001 6362 6369
61. P.S. Goldman-Rakic, and L.D. Selemon Functional and anatomical aspects of prefrontal pathology in schizophrenia Schizophr Bull 23 1997 437 458
62. G. Gonzalez-Burgos, and D.A. Lewis NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia Schizophr Bull 38 2012 950 957
63. E. Gramage, N. Del Olmo, A. Fole, Y.B. Martin, and G. Herradon Periadolescent amphetamine treatment causes transient cognitive disruptions and long-term changes in hippocampal LTP depending on the endogenous expression of pleiotrophin Addict Biol 18 2013 19 29
64. J.W. Grimm, L. Lu, T. Hayashi, B.T. Hope, T.P. Su, and Y. Shaham Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving J Neurosci 23 2003 742 747
65. J. Haggkvist, S. Lindholm, and J. Franck The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat Addict Biol 14 2009 260 269
66. J. Haggkvist, S. Lindholm, and J. Franck The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat Behav Brain Res 197 2009 219 224
67. M.E. Hasselmo The role of acetylcholine in learning and memory Curr Opin Neurobiol 16 2006 710 715
68. D.J. Hayes, and A.J. Greenshaw 5-HT receptors and reward-related behaviour: a review Neurosci Biobehav Rev 35 2011 1419 1449
69. D.J. Heal, S.C. Cheetham, and S.L. Smith The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety Neuropharmacology 57 2009 608 618
70. J.M. Henley, and K.A. Wilkinson AMPA receptor trafficking and the mechanisms underlying synaptic plasticity and cognitive aging Dialogues Clin Neurosci 15 2013 11 27
71. A. Hetzel, G.E. Meredith, D.J. Rademacher, and J.A. Rosenkranz Effect of amphetamine place conditioning on excitatory synaptic events in the basolateral amygdala ex vivo Neuroscience 206 2012 7 16
72. N. Hirai, and S. Nishino Recent advances in the treatment of narcolepsy Curr Treat Options Neurol 13 2011 437 457
73. P. Hodgkins, M. Shaw, S. McCarthy, and F.R. Sallee The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter? CNS Drugs 26 2012 245 268
74. B.A. Horger, C.A. Iyasere, M.T. Berhow, C.J. Messer, E.J. Nestler, and J.R. Taylor Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor J Neurosci 19 1999 4110 4122
75. O.D. Howes, and S. Kapur The dopamine hypothesis of schizophrenia: version III - the final common pathway Schizophr Bull 35 2009 549 562
76. A.C. Howlett, P.H. Reggio, S.R. Childers, R.E. Hampson, N.M. Ulloa, and D.G. Deutsch Endocannabinoid tone versus constitutive activity of cannabinoid receptors Br J Pharmacol 163 2011 1329 1343
77. Y.C. Huang, S.J. Wang, L.C. Chiou, and P.W. Gean Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala J Neurosci 23 2003 10311 10320
78. A. Imperato, M.C. Obinu, and G.L. Gessa Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus Eur J Pharmacol 238 1993 377 381
79. J. Innos, E. Leidmaa, M.A. Philips, S. Sutt, A. Alttoa, and J. Harro et al. Lsamp-/- mice display lower sensitivity to amphetamine and have elevated 5-HT turnover Biochem Biophys Res Commun 430 2013 413 418
80. D.S. Janowsky, and J.M. Davis Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms Arch Gen Psychiatry 33 1976 304 308
81. T.M. Jay Dopamine: a potential substrate for synaptic plasticity and memory mechanisms Prog Neurobiol 69 2003 375 390
82. N. Jayaram-Lindstrom, M. Konstenius, S. Eksborg, O. Beck, A. Hammarberg, and J. Franck Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence Neuropsychopharmacology 33 2008 1856 1863
83. N. Jayaram-Lindstrom, P. Wennberg, Y.L. Hurd, and J. Franck Effects of naltrexone on the subjective response to amphetamine in healthy volunteers J Clin Psychopharmacol 24 2004 665 669
84. D. Jody, J.A. Lieberman, S. Geisler, S. Szymanski, and J.M. Alvir Behavioral response to methylphenidate and treatment outcome in first episode schizophrenia Psychopharmacol Bull 26 1990 224 230
85. J. John, M.F. Wu, L.N. Boehmer, and J.M. Siegel Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior Neuron 42 2004 619 634
86. H. Jun, S. Mohammed Qasim Hussaini, M.J. Rigby, and M.H. Jang Functional role of adult hippocampal neurogenesis as a therapeutic strategy for mental disorders Neural Plast 2012 2012 854285
87. F. Karoum, S.J. Chrapusta, R. Brinjak, A. Hitri, and R.J. Wyatt Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain Br J Pharmacol 113 1994 1391 1399
88. S.E. Kennedy, R.A. Koeppe, E.A. Young, and J.K. Zubieta Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women Arch Gen Psychiatry 63 2006 1199 1208
89. A.S. Keys, and G.P. Mark D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens Neuroscience 86 1998 521 531
90. B. Kirkpatrick, W.S. Fenton, W.T. Carpenter Jr., and S.R. Marder The NIMH-MATRICS consensus statement on negative symptoms Schizophr Bull 32 2006 214 219
91. J. Kleijn, J. Wiskerke, T.I. Cremers, A.N. Schoffelmeer, B.H. Westerink, and T. Pattij Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation Neurochem Int 60 2012 791 798
92. G.F. Koob The neurobiology of addiction: a neuroadaptational view relevant for diagnosis Addiction 101 2006 23 30
93. M. Laruelle, A. Abi-Dargham, C.H. van Dyck, R. Gil, C.D. D'Souza, and J. Erdos et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects Proc Natl Acad Sci U S A 93 1996 9235 9240
94. R.A. Lasser, B. Dirks, H. Nasrallah, C. Kirsch, J. Gao, and M.L. Pucci et al. Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases Neuropsychopharmacology 38 2013 2140 2149
95. J. Le Merrer, J.A. Becker, K. Befort, and B.L. Kieffer Reward processing by the opioid system in the brain Physiol Rev 89 2009 1379 1412
96. S.H. Lee, and Y. Dan Neuromodulation of brain states Neuron 76 2012 209 222
97. V. Lessmann Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS Gen Pharmacol 31 1998 667 674
98. D.L. Levy, M. Smith, D. Robinson, D. Jody, G. Lerner, and J. Alvir et al. Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls Biol Psychiatry 34 1993 507 514
99. J.P. Lindenmayer, H. Nasrallah, M. Pucci, S. James, and L. Citrome A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities Schizophr Res 147 2013 241 252
100. J. Lisman, A.A. Grace, and E. Duzel A neoHebbian framework for episodic memory; role of dopamine-dependent late LTP Trends Neurosci 34 2011 536 547
101. B. Lu BDNF and activity-dependent synaptic modulation Learn Mem 10 2003 86 98
102. L. Lu, J. Dempsey, S.Y. Liu, J.M. Bossert, and Y. Shaham A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal J Neurosci 24 2004 1604 1611
103. W. Lu, and M.E. Wolf Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration Brain Res Mol Brain Res 49 1997 137 148
104. A.L. Mahan, and K.J. Ressler Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder Trends Neurosci 35 2012 24 35
105. R.C. Malenka, and M.F. Bear LTP and LTD: an embarrassment of riches Neuron 44 2004 5 21
106. F. Manago, S. Lopez, A. Oliverio, M. Amalric, A. Mele, and E. De Leonibus Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice Psychopharmacology (Berl) 226 2013 541 550
107. L. Mao, F. Conquet, and J.Q. Wang Augmented motor activity and reduced striatal preprodynorphin mRNA induction in response to acute amphetamine administration in metabotropic glutamate receptor 1 knockout mice Neuroscience 106 2001 303 312
108. L.M. Mao, W. Wang, X.P. Chu, G.C. Zhang, X.Y. Liu, and Y.J. Yang et al. Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine Nat Neurosci 12 2009 602 610
109. D. Marazziti, G. Consoli, M. Picchetti, M. Carlini, and L. Faravelli Cognitive impairment in major depression Eur J Pharmacol 626 2010 83 86
110. D.C. Mathews, I.D. Henter, and C.A. Zarate Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date Drugs 72 2012 1313 1333
111. B.J. Mattson, H.S. Crombag, T. Mitchell, D.E. Simmons, J.D. Kreuter, and M. Morales et al. Repeated amphetamine administration outside the home cage enhances drug-induced Fos expression in rat nucleus accumbens Behav Brain Res 185 2007 88 98
112. A.K. McAllister, L.C. Katz, and D.C. Lo Neurotrophins and synaptic plasticity Annu Rev Neurosci 22 1999 295 318
113. L.M. McDermott, and K.P. Ebmeier A meta-analysis of depression severity and cognitive function J Affect Disord 119 2009 1 8
114. J.F. McGinty, A.J. Bache, N.T. Coleman, and W.L. Sun The role of BDNF/TrkB signaling in acute amphetamine-induced locomotor activity and opioid peptide gene expression in the rat dorsal striatum Front Syst Neurosci 5 2011 60
115. R.S. McIntyre, M. Alsuwaidan, J.K. Soczynska, I. Szpindel, T.S. Bilkey, and D. Almagor et al. The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder Hum Psychopharmacol 28 2013 421 427
116. G.E. Meredith, S. Callen, and D.A. Scheuer Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration Brain Res 949 2002 218 227
117. M. Miele, M.A. Mura, P. Enrico, G. Esposito, P.A. Serra, and R. Migheli et al. On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats Br J Pharmacol 129 2000 582 588
118. D.J. Miklowitz, and S.L. Johnson The psychopathology and treatment of bipolar disorder Annu Rev Clin Psychol 2 2006 199 235
119. M.J. Millan Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors J Pharmacol Exp Ther 295 2000 853 861
120. H.H. Miller, P.A. Shore, and D.E. Clarke In vivo monoamine oxidase inhibition by d-amphetamine Biochem Pharmacol 29 1980 1347 1354
121. B. Moghaddam, and D. Javitt From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment Neuropsychopharmacology 37 2012 4 15
122. K.E. Moore Interactions between prolactin and dopaminergic neurons Biol Reprod 36 1987 47 58
123. T.I. Morgenthaler, V.K. Kapur, T. Brown, T.J. Swick, C. Alessi, and R.N. Aurora et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin Sleep 30 2007 1705 1711
124. M.M. Morshedi, D.J. Rademacher, and G.E. Meredith Increased synapses in the medial prefrontal cortex are associated with repeated amphetamine administration Synapse 63 2009 126 135
125. C.L. Nelson, M. Milovanovic, J.B. Wetter, K.A. Ford, and M.E. Wolf Behavioral sensitization to amphetamine is not accompanied by changes in glutamate receptor surface expression in the rat nucleus accumbens J Neurochem 109 2009 35 51
126. K.H. Nuechterlein, D.M. Barch, J.M. Gold, T.E. Goldberg, M.F. Green, and R.K. Heaton Identification of separable cognitive factors in schizophrenia Schizophr Res 72 2004 29 39
127. A. Olincy, and R. Freedman Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the alpha7 nicotinic receptor Handb Exp Pharmacol 211-232 2012
128. M.F. Olive, H.N. Koenig, M.A. Nannini, and C.W. Hodge Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine J Neurosci 21 2001 RC184
129. S.K. Olsson, A.S. Andersson, K.R. Linderholm, M. Holtze, L.K. Nilsson-Todd, and L. Schwieler et al. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia Int J Neuropsychopharmacol 12 2009 501 512
130. F. Orrego, and S. Villanueva The chemical nature of the main central excitatory transmitter: a critical appraisal based upon release studies and synaptic vesicle localization Neuroscience 56 1993 539 555
131. O.A. Panagiotou, D.G. Contopoulos-Ioannidis, P.N. Papanikolaou, E.E. Ntzani, and J.P. Ioannidis Different black box warning labeling for same-class drugs J Gen Intern Med 26 2011 603 610
132. N.K. Parelkar, and J.Q. Wang Upregulation of metabotropic glutamate receptor 8 mRNA expression in the rat forebrain after repeated amphetamine administration Neurosci Lett 433 2008 250 254
133. A.A. Patkar, P.S. Masand, C.U. Pae, K. Peindl, C. Hooper-Wood, and P. Mannelli et al. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression J Clin Psychopharmacol 26 2006 653 656
134. E.A. Pehek, and Y. Bi Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex Prog Neuropsychopharmacol Biol Psychiatry 21 1997 671 682
135. A.L. Pehrson, and B. Moghaddam Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion Psychopharmacology (Berl) 211 2010 443 455
136. R.G. Pertwee Emerging strategies for exploiting cannabinoid receptor agonists as medicines Br J Pharmacol 156 2009 397 411
137. N.S. Philip, L.L. Carpenter, A.R. Tyrka, and L.H. Price The nicotinic acetylcholine receptor as a target for antidepressant drug development ScientificWorldJournal 2012 2012 104105
138. M.R. Picciotto, M.J. Higley, and Y.S. Mineur Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior Neuron 76 2012 116 129
139. G. Porras, V. Di Matteo, C. Fracasso, G. Lucas, P. De Deurwaerdere, and S. Caccia et al. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum Neuropsychopharmacology 26 2002 311 324
140. T.T. Postolache, R.N. Rosenthal, D.J. Hellerstein, R. Aromin, G.M. Kelton, and J.C. Muran et al. Early augmentation of sertraline with methylphenidate J Clin Psychiatry 60 1999 123 124
141. A.A. Pradhan, K. Befort, C. Nozaki, C. Gaveriaux-Ruff, and B.L. Kieffer The delta opioid receptor: an evolving target for the treatment of brain disorders Trends Pharmacol Sci 32 2011 581 590
142. W.M. Qu, X.H. Xu, M.M. Yan, Y.Q. Wang, Y. Urade, and Z.L. Huang Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice J Neurosci 30 2010 4382 4389
143. D.J. Rademacher, J.A. Rosenkranz, M.M. Morshedi, E.M. Sullivan, and G.E. Meredith Amphetamine-associated contextual learning is accompanied by structural and functional plasticity in the basolateral amygdala J Neurosci 30 2010 4676 4686
144. K.M. Raehal, C.L. Schmid, C.E. Groer, and L.M. Bohn Functional selectivity at the mu-opioid receptor: implications for understanding opioid analgesia and tolerance Pharmacol Rev 63 2011 1001 1019
145. S. Rahman, and M.T. Bardo Environmental enrichment increases amphetamine-induced glutamate neurotransmission in the nucleus accumbens: a neurochemical study Brain Res 1197 2008 40 46
146. A.V. Ravindran, S.H. Kennedy, M.C. O'Donovan, A. Fallu, F. Camacho, and C.E. Binder Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial J Clin Psychiatry 69 2008 87 94
147. M.C. Ritz, and M.J. Kuhar Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine J Pharmacol Exp Ther 248 1989 1010 1017
148. M.C. Ritz, R.J. Lamb, S.R. Goldberg, and M.J. Kuhar Cocaine receptors on dopamine transporters are related to self-administration of cocaine Science 237 1987 1219 1223
149. S.D. Robertson, H.J. Matthies, and A. Galli A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters Mol Neurobiol 39 2009 73 80
150. J.B. Robinson Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl Biochem Pharmacol 34 1985 4105 4108
151. R.B. Rothman, and M.H. Baumann Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs Ann N Y Acad Sci 1074 2006 245 260
152. H.G. Ruhe, N.S. Mason, and A.H. Schene Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies Mol Psychiatry 12 2007 331 359
153. M. Rutkowska, J. Jamontt, and H. Gliniak Effects of cannabinoids on the anxiety-like response in mice Pharmacol Rep 58 2006 200 206
154. R. Saba, P.H. Storchel, A. Aksoy-Aksel, F. Kepura, G. Lippi, and T.D. Plant et al. Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons Mol Cell Biol 32 2012 619 632
155. G. Sanacora, G. Treccani, and M. Popoli Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders Neuropharmacology 62 2012 63 77
156. P.J. Santosh, S. Sattar, and M. Canagaratnam Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults CNS Drugs 25 2011 737 763
157. J. Savitz, I. Lucki, and W.C. Drevets 5-HT(1A) receptor function in major depressive disorder Prog Neurobiol 88 2009 17 31
158. A.J. Saylor, and J.F. McGinty Amphetamine-induced locomotion and gene expression are altered in BDNF heterozygous mice Genes Brain Behav 7 2008 906 914
159. J.L. Scholl, N. Feng, M.J. Watt, K.J. Renner, and G.L. Forster Individual differences in amphetamine sensitization, behavior and central monoamines Physiol Behav 96 2009 493 504
160. M. Seixas, M. Weiss, and U. Muller Systematic review of national and international guidelines on attention-deficit hyperactivity disorder J Psychopharmacol 26 2011 753 765
161. C. Shaffer, M.L. Guo, E.E. Fibuch, L.M. Mao, and J.Q. Wang Regulation of group I metabotropic glutamate receptor expression in the rat striatum and prefrontal cortex in response to amphetamine in vivo Brain Res 1326 2010 184 192
162. L.H. Shen, M.H. Liao, and Y.C. Tseng Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders J Biomed Biotechnol 2012 2012 259349
163. F. Shen, G.E. Meredith, and T.C. Napier Amphetamine-induced place preference and conditioned motor sensitization requires activation of tyrosine kinase receptors in the hippocampus J Neurosci 26 2006 11041 11051
164. P.C. Suen, K. Wu, E.S. Levine, H.T. Mount, J.L. Xu, and S.Y. Lin et al. Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-D-aspartate receptor subunit 1 Proc Natl Acad Sci U S A 94 1997 8191 8195
165. D. Sulzer How addictive drugs disrupt presynaptic dopamine neurotransmission Neuron 69 2011 628 649
166. X. Sun, Y. Zhao, and M.E. Wolf Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons J Neurosci 25 2005 7342 7351
167. J. Swanson, R.D. Baler, and N.D. Volkow Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress Neuropsychopharmacology 36 2011 207 226
168. S. Taheri, J.M. Zeitzer, and E. Mignot The role of hypocretins (orexins) in sleep regulation and narcolepsy Annu Rev Neurosci 25 2002 283 313
169. E.T. Tzavara, A. Degroot, M.R. Wade, R.J. Davis, and G.G. Nomikos CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: role of mGlu5 receptors Eur Neuropsychopharmacol 19 2009 196 204
170. S.S. Valvassori, G. Elias, B. de Souza, F. Petronilho, F. Dal-Pizzol, and F. Kapczinski et al. Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania J Psychopharmacol 25 2011 274 280
171. M. van den Buuse, E. Ruimschotel, S. Martin, V.B. Risbrough, and A.L. Halberstadt Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout
172. D.P. van Kammen, and J.J. Boronow Dextro-amphetamine diminishes negative symptoms in schizophrenia Int Clin Psychopharmacol 3 1988 111 121
173. R.A. Vaughan, and J.D. Foster Mechanisms of dopamine transporter regulation in normal and disease states Trends Pharmacol Sci 34 2013 489 496
174. B. Vaughan, and C.J. Kratochvil Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder Child Adolesc Psychiatr Clin N Am 21 2012 941 955
175. E. Walderhaug, M. Varga, M. San Pedro, J. Hu, and A. Neumeister The role of the aminergic systems in the pathophysiology of bipolar disorder In Behavioral Neurobiology Of Bipolar Disorder And Its Treatment 2011 Springer 107 126
176. J.Q. Wang, and J.F. McGinty D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine Synapse 22 1996 114 122
177. S. Wee, and G.F. Koob The role of the dynorphin-κ opioid system in the reinforcing effects of drugs of abuse Psychopharmacology (Berl) 210 2010 121 135
178. A.N. Westover, and E.A. Halm Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review BMC Cardiovasc Disord 12 2012 41
179. J.P. Wisor, S. Nishino, I. Sora, G.H. Uhl, E. Mignot, and D.M. Edgar Dopaminergic role in stimulant-induced wakefulness J Neurosci 21 2001 1787 1794
180. M.E. Wolf, X. Sun, S. Mangiavacchi, and S.Z. Chao Psychomotor stimulants and neuronal plasticity Neuropharmacology 47 2004 61 79
181. M.L. Woolley, D.J. Pemberton, S. Bate, C. Corti, and D.N. Jones The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity Psychopharmacology (Berl) 196 2008 431 440
182. Y.F. Xia, L. He, J.L. Whistler, and G.O. Hjelmstad Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens Neuropsychopharmacology 33 2008 892 900
183. T.X. Xu, Q. Ma, R.D. Spealman, and W.D. Yao Amphetamine modulation of long-term potentiation in the prefrontal cortex: dose dependency, monoaminergic contributions, and paradoxical rescue in hyperdopaminergic mutant J Neurochem 115 2010 1643 1654
184. C.J. Xue, J.P. Ng, Y. Li, and M.E. Wolf Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens J Neurochem 67 1996 352 363
185. D.S. Zahm, and M. Trimble The dopaminergic projection system, basal forebrain macrosystems, and conditioned stimuli CNS Spectr 13 2008 32 40
186. J.Y. Zhou, Z.X. Mo, and S.W. Zhou Effect of rhynchophylline on central neurotransmitter levels in amphetamine-induced conditioned place preference rat brain Fitoterapia 81 2010 844 848
187. M.Y. Zhu, S. Shamburger, J. Li, and G.A. Ordway Regulation of the human norepinephrine transporter by cocaine and amphetamine J Pharmacol Exp Ther 295 2000 951 959